Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses

BackgroundProstate cancer in men's health has become a significant driver of global disease burden, impacting aging populations worldwide. This study assesses its prevalence from 1990 to 2021 to reveal ongoing epidemiological trends and inform effective public health strategies.MethodsProstate...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaohu Zhao, Shuchen Liu, Zhihui Zou, Chaozhao Liang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Public Health
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2025.1595159/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849331939146727424
author Xiaohu Zhao
Shuchen Liu
Zhihui Zou
Chaozhao Liang
author_facet Xiaohu Zhao
Shuchen Liu
Zhihui Zou
Chaozhao Liang
author_sort Xiaohu Zhao
collection DOAJ
description BackgroundProstate cancer in men's health has become a significant driver of global disease burden, impacting aging populations worldwide. This study assesses its prevalence from 1990 to 2021 to reveal ongoing epidemiological trends and inform effective public health strategies.MethodsProstate cancer prevalence estimates, including their 95% uncertainty intervals (UIs), were derived from the Global Burden of Disease (GBD) 2021 study. Then, temporal trends spanning the past 32 years were thoroughly analyzed using Joinpoint regression, with projections for the next 25 years made using the Bayesian Age-Period-Cohort (BAPC) model. Concurrently, disease trends were decomposed into components of population growth, aging, and epidemiological changes. Additionally, age-period-cohort (APC) models were also employed to explore the impact of age, time, and cohort effect on the relative risk of prostate cancer prevalence. And the cross-country inequalities in the prevalence of prostate cancer burden were meticulously evaluated through the Socio-Demographic Index (SDI), revealing significant disparities across socio-economic strata.ResultIn 2021, over 10 million prostate cancer cases were recorded worldwide—a 188.85% increase from 3.6 million in 1990. The age-standardized prevalence rate (ASPR) rose at an estimated annual percentage change of 0.64% (95% UI: 0.47%−0.82%); Joinpoint regression revealed a steady increase in case numbers over 32 years, while the ASPR peaked and then slightly declined. Decomposition analysis showed population growth as the main driver (65.62%), with epidemiological changes and aging accounting for 17.97 and 16.41%, respectively. APC modeling indicated the highest relative risk around age 75—nearly 10 times that of the general population (RR: 9.99; 95% CI: 9.97–10.01). Projections through 2046 forecast a continued rise in both total cases and ASPR.ConclusionsAs a major health concern among older adult men, the global prevalence of prostate cancer has risen steadily since 1990, with population growth identified as the primary driver. Moreover, SDI-related disparities across 204 countries and territories have widened over time. Finally, the APC model forecasts a continuous increase in prevalence over the next 25 years, underscoring the growing disease burden and the urgent need for more targeted and effective management strategies.
format Article
id doaj-art-fee307a990574c2daa63f0cb9fc0e626
institution Kabale University
issn 2296-2565
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Public Health
spelling doaj-art-fee307a990574c2daa63f0cb9fc0e6262025-08-20T03:46:21ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-06-011310.3389/fpubh.2025.15951591595159Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analysesXiaohu ZhaoShuchen LiuZhihui ZouChaozhao LiangBackgroundProstate cancer in men's health has become a significant driver of global disease burden, impacting aging populations worldwide. This study assesses its prevalence from 1990 to 2021 to reveal ongoing epidemiological trends and inform effective public health strategies.MethodsProstate cancer prevalence estimates, including their 95% uncertainty intervals (UIs), were derived from the Global Burden of Disease (GBD) 2021 study. Then, temporal trends spanning the past 32 years were thoroughly analyzed using Joinpoint regression, with projections for the next 25 years made using the Bayesian Age-Period-Cohort (BAPC) model. Concurrently, disease trends were decomposed into components of population growth, aging, and epidemiological changes. Additionally, age-period-cohort (APC) models were also employed to explore the impact of age, time, and cohort effect on the relative risk of prostate cancer prevalence. And the cross-country inequalities in the prevalence of prostate cancer burden were meticulously evaluated through the Socio-Demographic Index (SDI), revealing significant disparities across socio-economic strata.ResultIn 2021, over 10 million prostate cancer cases were recorded worldwide—a 188.85% increase from 3.6 million in 1990. The age-standardized prevalence rate (ASPR) rose at an estimated annual percentage change of 0.64% (95% UI: 0.47%−0.82%); Joinpoint regression revealed a steady increase in case numbers over 32 years, while the ASPR peaked and then slightly declined. Decomposition analysis showed population growth as the main driver (65.62%), with epidemiological changes and aging accounting for 17.97 and 16.41%, respectively. APC modeling indicated the highest relative risk around age 75—nearly 10 times that of the general population (RR: 9.99; 95% CI: 9.97–10.01). Projections through 2046 forecast a continued rise in both total cases and ASPR.ConclusionsAs a major health concern among older adult men, the global prevalence of prostate cancer has risen steadily since 1990, with population growth identified as the primary driver. Moreover, SDI-related disparities across 204 countries and territories have widened over time. Finally, the APC model forecasts a continuous increase in prevalence over the next 25 years, underscoring the growing disease burden and the urgent need for more targeted and effective management strategies.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1595159/fullprostate cancerprevalenceGlobal Burden of Disease study 2021health inequalitynational
spellingShingle Xiaohu Zhao
Shuchen Liu
Zhihui Zou
Chaozhao Liang
Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses
Frontiers in Public Health
prostate cancer
prevalence
Global Burden of Disease study 2021
health inequality
national
title Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses
title_full Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses
title_fullStr Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses
title_full_unstemmed Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses
title_short Global, regional, and national prevalence of prostate cancer from 1990 to 2021: a trend and health inequality analyses
title_sort global regional and national prevalence of prostate cancer from 1990 to 2021 a trend and health inequality analyses
topic prostate cancer
prevalence
Global Burden of Disease study 2021
health inequality
national
url https://www.frontiersin.org/articles/10.3389/fpubh.2025.1595159/full
work_keys_str_mv AT xiaohuzhao globalregionalandnationalprevalenceofprostatecancerfrom1990to2021atrendandhealthinequalityanalyses
AT shuchenliu globalregionalandnationalprevalenceofprostatecancerfrom1990to2021atrendandhealthinequalityanalyses
AT zhihuizou globalregionalandnationalprevalenceofprostatecancerfrom1990to2021atrendandhealthinequalityanalyses
AT chaozhaoliang globalregionalandnationalprevalenceofprostatecancerfrom1990to2021atrendandhealthinequalityanalyses